Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Stocks to Bet On if You Need Fast Cash

With the market potentially baking in much of the bad news, these are the fast money stocks to buy for contrarian traders.

7 Cryptos to Watch as the Sector Risks Hibernation

With the Federal Reserve committed to killing inflation, the narrative for cryptos should focus on long-term accumulation.

Canadian Solar (CSIQ) Stock Falls Despite Earnings Beat

Although Canadian Solar beat profit expectations for its Q3 report, unfavorable cost structures for the industry hurt CSIQ stock.

ZM Stock: What to Watch as Zoom Reports Earnings Today

With Zoom reporting Q3 earnings today following the closing bell, investors are concerned about competition and relevancy risks for ZM stock.

Why Is Helbiz (HLBZ) Stock Trending Today?

Helbiz captured headlines when it announced both a merger completion and cost cuts, though neither helped HLBZ stock on Monday.

7 Sin Stocks That Can Weather a Recessionary Storm

While boring might be best during a possible economic downturn, these sin stocks provide a tempting alternative to your portfolio.

7 Short-Squeeze Stocks for Bold Contrarians to Consider

While market volatility has brough the bears out of hibernation, certain short-squeeze stocks could be a trap for the pessimists.

7 Utility Stocks to Buy Heading Into December 2022

With possibly choppy waters ahead in the global economy, investors may want to seek shelter in utility stocks to buy.

7 Millionaire-Maker Tech Stocks You Will Regret Not Buying This Year

While macroeconomic pressures hurt the innovation sector, it also opened doors for millionaire-maker tech stocks to buy.

Why Is Iveric Bio (ISEE) Stock Up 25% Today?

Biotechnology firm Iveric Bio shot up on a regulatory green light for its key therapeutic, sparking interest in high-risker play ISEE stock.